December 15, 2021 December 15, 2021Categories Ongoing TrialsOngoing Trial: Clinical trial EA5182 is testing the addition of a drug to the most commonly used first treatment for patients with lung cancer that has spreadThis study is exploring a new treatment option for patients with advanced (metastatic) non-small cell lung cancer that has the EGFR gene mutation
December 15, 2021 December 15, 2021Categories Trial ResultsTrial Results: The DREAMseq trial provides strong evidence for a new treatment sequence for patients with BRAF-mutated advanced melanoma skin cancerDr. Michael Atkins, a medical oncologist who specializes in melanoma, talks about the results of the DREAMseq trial and how the information will hopefully extend life for more patients with advanced melanoma
June 24, 2021 June 24, 2021Categories EditorialsOngoing Trial: For patients with advanced or rare cancers, NCI-MATCH may offer a treatment optionEach arm of NCI-MATCH—and every patient who participates—provide valuable information on potential cancer treatments.
February 12, 2020 February 12, 2020Categories Trial ResultsTrial Results: New TAILORx data shows chemotherapy benefit for women at high risk of breast cancer recurrenceThe TAILORx trial answers questions about when to use chemotherapy to treat the most common type of breast cancer.